Abstract:OBJECTIVE:Applying multiplex PCR and multiplex ligation-dependent probe amplification (MLPA) in a clinical setting to detect deletions and duplications in the Duchenne/Becker muscular dystrophy (DMD/BMD) gene not only for patients, but also for identification of possible carriers and prenatal diagnosis. METHODS:Multiplex PCR was used first in patients clinically diagnosed with DMD/BMD to examine 26 exons for a large deletion in the two hot regions of the dystrophin gene. For patients without a deletion detected in the aforementioned regions, MLPA was used to further examine all 79 exons to determine whether a deletion in the remaining non-hot regions or any duplication was present. A similar approach was applied to suspected carriers. In requested prenatal diagnosis cases, specific PCR was used to detect deletions, while MLPA was applied to detect duplications. RESULTS:Multiplex PCR was used to examine 26 exons within the two hot regions in the Dystrophin gene for 22 patients with DMD; 13 (13/22) had multi-exon deletions. For the 9 patients without deletions in the 26 exons, MLPA was used to examine 79 exons. 3 patients had duplications, 1 patient had a single deletion in exon 18, and no deletions or duplications could be detected in the remaining 5 patients. Of the 16 carriers, 2 out of the 3 that had family history had deletions, while the other 13 carriers were mothers of affected children who were sporadic patients without family history. Of them, 8 mothers were carriers for either deletions or duplications. For prenatal diagnosis, 9 fetuses were examined (one case was twins). Of them, 2 fetuses had familial deletions or duplications detected. These results were verified after induced abortion. In 7 fetuses, no deletions or duplications were detected and all developed into children. CONCLUSION:Multiplex PCR can detect 92.86% of deletions and is useful for prenatal diagnosis of deletions because it is simple, reliable and inexpensive. It can be the first choice in DMD/BMD gene diagnosis. MLPA is important for detecting deletions in non-hot regions/exons and duplications in the DMD/BMD gene, as well as for carrier detection.

Preimplantational Genetic Diagnosis and Mutation Detection in A Family with Duplication Mutation of Dmd Gene

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

[Mutation Analysis and Prenatal Diagnosis for 50 Pedigrees Affected with Duchenne/Becker Muscular Dystrophy].

[Prenatal Diagnosis of Spinal Muscular Atrophy Using Multiple Ligation-Dependent Probe Amplification].

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

Generation of Five Induced Pluripotent Stem Cell Lines with DMD/c.497G > T Mutation from Renal Epithelial Cells of a Duchenne Muscular Dystrophy Patient and a Recessive Carrier Parent

Study on Duchenne muscular dystrophy gene mutation and prenatal diagnosis]

Preimplantation Genetic Diagnosis of Duchenne Muscular Dystrophy by Single Cell Triplex PCR

Prenatal Gene Diagnosis for the Duchenne Muscular Dystrophy Risk Fetus by Molecule Markers

Mutation and Haplotype Analysis for Duchenne Muscular Dystrophy by Single Cell Multiple Displacement Amplification.

Preimplantation Genetic Diagnosis for Duchenne Muscular Dystrophy by Multiple Displacement Amplification.

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

[Mutation analysis and prenatal diagnosis of sporadic DMD/BMD families].

Preimplantation Genetic Diagnosis of Duchenne Muscular Dystrophy (DMD)

Prenatal Diagnosis of Duchenne Muscular Dystrophy in 131 Chinese Families with Dystrophinopathy

Application of trigeminy-PCR in prenatal diagnosis of Duchenne/Becker muscular dystrophy

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

Unexpected DMD Gene Mutations Detected by CMA and CNV-seq in Amniotic Fluid and Aborted Fetus Samples

Development of a Comprehensive Real-Time PCR Assay for Dystrophin Gene Analysis and Prenatal Diagnosis of Chinese Families.

[Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].

Identification of Two Rare Mutations C.1318g>a and C.6438+2t>g in a Chinese DMD Family As Genetic Markers